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CANCER OF THE BREAST is the most com-
monly occurring neoplasm in women, and
consequently has been the subject of inten-
sive study. Mammary cancer also occurs
spontaneously in rats and mice, and these
species have been the most frequently used
in laboratory investigations. By now, it is
well known that neoplasia in the mammary
gland can be influenced by a variety of fac-
tors. Genetic, hormonal, viral, immunological,
dietary and other environmental factors are
involved in varying degrees in determining
spontaneous mammary cancer in rodents
(Nandi & McGrath, 1973).
Chemical induction of mammary neoplasia
has been studied experimentally in rodents
after treatment with hormones and chemical
carcinogens.
Induction of mammary cancer by hormones
A high incidence of mammary cancers has
been induced in rats and mice by administra-
tion of natural and synthetic steroidal and
non-steroidal oestrogens, and anterior-pitui-
tary hormones. Frequency of tumour induc-
tion varies with strain, but in all cases the
hormone must be given continuously over a
long period of time at levels much above the
physiological replacement dose. Depending
on dose, latent periods can vary from 100 to
700 days (Jull, 1976; Lacassagne, 1937).
Pituitary adenomas accompany the ap-
pearance of mammary cancer, and such ob-
servations have led to the hypothesis that
oestrogens are oncogenic because of their
stimulatory effect on prolactin secretion
(Firth, 1973). Despite numerous experiments
involving endocrine manipulation, the ques-
tion whether oestrogens exert their effect on
mammary tissue directly or indirectly re-
mains unanswered.
Diethylstilboestrol (DES) administered at
20 pts/106 in the diet produced mammary
carcinomas in 80% of treated rats by 40
weeks. Sequential studies of the mammary
tissue before neoplasia revealed an accelerated
physiological ageing of the gland. Early
development of lobulo-alveolar hyperplasia
was followed by degenerative changes and
cyst formation; focal dysplastic changes were
seen in areas of epithelium lining the cysts,
which progressed to malignancy. In some
animals, malignant change was limited to
discrete areas within one gland; in others all
mammary glands were neoplastic. Pituitary
adenomas were found in all treated rats, and
immunohistochemical staining revealed an
increase in prolactin-secreting cells. Atrophy
of uterine and ovarian tissues also occurred.
Hypophysectomy or treatment with bromo-
criptine, a specific inhibitor of prolactin
secretion, abolished the neoplastic response,
but oophorectomy had no effect on tumour
induction.
Similar changes have been found in mam-
mary tissue of rodents administered natural
oestrogens (Geschicter, 1945).
Induction of mammary cancer by chemical
carcinogens
Mammary tumours have been induced in
rats and mice after brief administration of
aminofluorenes, polycyclic aromatic hydro-
carbons or alkylnitrosamides. Frequency of
induced tumours varied with the strain and
age of the rodent, as well as with the type of
carcinogen, dose and route of administration
(Armstrong & Bonser, 1947; Bonser & Orr,
1939; Young & Hallowes, 1973).
N-methyl-N-nitrosourea (MNU) (5 mg/
100 g) administered to rats, produced 100%
incidence of mammary carcinomas, the first
tumours arising by 7 weeks. Sequential analy-
sis ofmammary tissue before tumour develop-
ment did not reveal anyhyperplastic changes.
Tumours arose abruptly from ductular struc-
tures in the unstimulated gland. Pituitary
histology was normal, as were other endocrine
glands. However, hypophysectomy oroophor-
ectomy before MNU administration abolished
the neoplastic response.
Similar results have been reported with
DMBA and 3-methylcholanthrene (Young &
Hallowes, 1973). The presence of certain
hormones appears to be a sine qua non in the
induction ofcancerby carcinogenic chemicals.
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In the Berenblum hypothesis of 2-stage
carcinogenesis, hormones apparently partici-
pate at both stages. Physiological levels of
hormones are necessary for initiation to occur.
Pathological levels of hormones can act as
promoters on transformed epithelium. Under
certain conditions it is also believed that they
can act as anti-promoters (Welch & Naga-
sawa, 1977).
Comment
From the above account it is clear that
different mechanisms of carcinogenicity exist
in the rodent mammary gland. The produc-
tion of mammary tumours by chemicals in
routine toxicity tests must be examined
critically in the light of such knowledge. Itis
important to distinguish between carcino-
genesis mediated by a direct effect ofthe test
chemical on mammary epithelium, and car-
cinogenesis elicited by an indirect action on
known modulators of mammary neoplasia.
Indirect action via hormonal pathways has
been described, but other pathways may also
be involved. For a final assessment of the
carcinogenic potential ofchemicalsinhumans,
an appreciation of such mechanisms is
essential.
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ONCOGENIC VIRUSES have been identified
in several mammalian species such as mouse,
rat, cat, dog and primates, and there is
indirect evidence that they may also be
present in man for a limited number of
tumours, e.g. Burkitt's lymphoma, Hodgkin's
disease and nasopharyngeal carcinoma.
Mice harbour a variety ofoncogenic viruses,
particularly the so-called lymphoma viruses.
They form part ofthe genetic make-up ofthe
mouse, and appear to be activated unpre-
dictably by a number of factors. This may
account for the variable incidence of lympho-
mas in successive generations ofmice.